Lectin-mediated mucosal delivery of drugs and microparticles.
about
The Potential of Silk and Silk-Like Proteins as Natural Mucoadhesive Biopolymers for Controlled Drug DeliveryUse of lectin-functionalized particles for oral immunotherapyNanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeuticsIntracellular delivery of nanoparticles of an antiasthmatic drug.Targeting approaches to oral drug delivery.Buccal delivery systems.Distribution patterns of carbohydrates in murine glycocalyxOral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.The role of adjuvants in the development of mucosal vaccines.A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methodsParticle uptake by Peyer's patches: a pathway for drug and vaccine delivery.Peyer's patches and M cells as potential sites of the inflammatory onset in Crohn's disease.Polymeric nanoparticle drug delivery technologies for oral delivery applications.Implication of nanoparticles/microparticles in mucosal vaccine delivery.Engineering strategies to enhance nanoparticle-mediated oral delivery.Nanotechnology-Based Approach in Tuberculosis Treatment.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Strategies for enhanced peptide and protein delivery.Novel strategies for the buccal delivery of macromolecules.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview.Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.Transport and uptake effects of marine complex lipid liposomes in small intestinal epithelial cell models.Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.In vitro toxicity assessment of silver nanoparticles in the presence of phenolic compounds--preventive agents against the harmful effect?Liposome-encapsulated midazolam for oral administration.Multistage Continuous Targeting with Quantitatively Controlled Peptides on Chitosan-Lipid Nanoparticles with Multicore-Shell Nanoarchitecture for Enhanced Orally Administrated Anticancer In Vitro and In Vivo.Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.Boronate-Containing PolymersMucoadhesive and enzymatic inhibitory nanoparticles for transnasal insulin delivery
P2860
Q26774443-9AF4E401-7EAB-46C3-868B-4D546C18A8BDQ26849550-CFEAC3E8-59E4-4E8D-9401-7FB4D3D38B23Q30391507-FFFA99A3-87A2-4147-BF9F-EE44BC2921F8Q34265610-221FF900-8116-491B-8909-3AA8FB40168FQ34293427-F58F31B0-694B-4639-A3D9-501797993C53Q34482068-08951641-BDE3-4590-99CD-CB5271885118Q35564695-6325C2D3-0C79-424D-96D4-6CE85318B828Q35644348-4FF759A8-22C7-4B0C-B1C8-3315B0CB6EC7Q35877982-24C1618D-4F06-49F6-9084-B882547A8A7FQ36194084-AFF5EF35-17C6-4B7B-A61E-288F968E6EEEQ36215627-BD4057E0-B30B-4422-94A2-CEFE89635528Q36316646-57E022E3-A18A-46CB-9E57-A679E513DA2FQ36631460-0AC772B7-CAB8-4A32-9A34-13C61A916E73Q36808308-0BB04ADB-F999-44FB-B521-3A283312DAE4Q36837152-2FCB8390-3C18-4DBF-9B01-450BF9E37F89Q37328673-BD92493C-5BB8-4C6C-A903-3D623B823057Q37624974-555A9C27-C4CD-468C-8DB8-ECB1797A0EBFQ38067265-AE5E409A-CF39-45F6-A8CA-129B00ABCECAQ38104408-E749E350-82AE-4A5F-9C30-287122A1FE03Q38194614-6C8A2A15-477E-4822-ACA5-A70ACAA001F0Q38266101-B441C71D-8A3E-4B62-B8E0-563DBAEFF9B8Q38689914-68BACA82-4CCE-414C-A71C-8CF0C8B20023Q39257007-0052E945-FCB4-4D36-9BE9-C16E848C49A2Q39899962-2B8689DB-11FD-4737-97B1-FEFD8D3B8E11Q45030426-986A0CE3-4AF6-460E-A638-BEAED522C81BQ45239979-45C6A58B-DD3C-4BA8-A1F5-47E8973A1C46Q48337514-D7B4B2F8-9A97-45F6-A4D3-57A7B853B6F4Q51162276-33ABCEC7-3A08-4D70-9E07-86B9F5F09A20Q55223335-1499BC3C-3F87-4A7C-BC14-7E8639924D21Q57341901-B24B33EA-CEF6-4C30-9482-85BB0899FBC7Q57382570-639788A0-D95B-4225-B2BC-C3CE3E48223D
P2860
Lectin-mediated mucosal delivery of drugs and microparticles.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lectin-mediated mucosal delivery of drugs and microparticles.
@ast
Lectin-mediated mucosal delivery of drugs and microparticles.
@en
Lectin-mediated mucosal delivery of drugs and microparticles.
@nl
type
label
Lectin-mediated mucosal delivery of drugs and microparticles.
@ast
Lectin-mediated mucosal delivery of drugs and microparticles.
@en
Lectin-mediated mucosal delivery of drugs and microparticles.
@nl
prefLabel
Lectin-mediated mucosal delivery of drugs and microparticles.
@ast
Lectin-mediated mucosal delivery of drugs and microparticles.
@en
Lectin-mediated mucosal delivery of drugs and microparticles.
@nl
P2093
P1476
Lectin-mediated mucosal delivery of drugs and microparticles.
@en
P2093
P304
P356
10.1016/S0169-409X(00)00070-3
P407
P577
2000-09-01T00:00:00Z